- Causal association between 731 immunocyte phenotypes and liver cirrhosis: A bidirectional two-sample mendelian randomization analysis
- Browse: 80 Download: 100 Issue Date: 2024-08-22
- Blood cell counts and nonalcoholic fatty liver disease: Evidence from Mendelian randomization analysis
- Browse: 82 Download: 92 Issue Date: 2024-08-22
- Successful treatment of acute liver failure due to Wilson’s disease: Serendipity or fortuity?
- Browse: 57 Download: 76 Issue Date: 2024-08-22
- Bridging the gap: Addressing disparities in hepatitis C screening, access to care, and treatment outcomes
- Browse: 71 Download: 58 Issue Date: 2024-08-22
- Rocahepevirus ratti: An underrecognised cause of acute hepatitis
- Browse: 62 Download: 83 Issue Date: 2024-08-22
- Improvement of hepatic fibrosis after tenofovir disoproxil fumarate switching to tenofovir alafenamide for three years
- Browse: 138 Download: 162 Issue Date: 2024-07-26
- Chronic hepatitis B virus infection in Eastern Ethiopia: Clinical characteristics and determinants of cirrhosis
- Browse: 167 Download: 199 Issue Date: 2024-07-26
- Predictive value of serum alanine aminotransferase for fatty liver associated with metabolic dysfunction
- Browse: 132 Download: 143 Issue Date: 2024-07-26
- Interleukin-mediated therapies in liver diseases and comorbidity effects
- Browse: 133 Download: 200 Issue Date: 2024-07-26
- Roles of transforming growth factor-β signaling in liver disease
- Browse: 163 Download: 142 Issue Date: 2024-07-26
- Successful treatment of severe hepatic impairment in erythropoietic protoporphyria: A case report and review of literature
- Browse: 122 Download: 191 Issue Date: 2024-06-27
- Liver histological changes in untreated chronic hepatitis B patients in indeterminate phase
- Browse: 91 Download: 223 Issue Date: 2024-06-27
- Importance of the gut microbiota in the gut-liver axis in normal and liver disease
- Browse: 99 Download: 136 Issue Date: 2024-06-27
- Sarcopenia and metabolic dysfunction associated steatotic liver disease: Time to address both
- Browse: 98 Download: 119 Issue Date: 2024-06-27
- Immunological crossroads: The intriguing dance between hepatitis C and autoimmune hepatitis
- Browse: 91 Download: 131 Issue Date: 2024-06-27
- Ornithine aspartate effects on bacterial composition and metabolic pathways in a rat model of steatotic liver disease
- Browse: 113 Download: 280 Issue Date: 2024-05-27
- Current concepts in the management of non-cirrhotic non-malignant portal vein thrombosis
- Browse: 93 Download: 148 Issue Date: 2024-05-27
- Nano-revolution in hepatocellular carcinoma: A multidisciplinary odyssey - Are we there yet?
- Browse: 89 Download: 117 Issue Date: 2024-05-27
- Liver disease in patients with transfusion-dependent β-thalassemia: The emerging role of metabolism dysfunction-associated steatotic liver disease
- Browse: 104 Download: 103 Issue Date: 2024-05-27
- Hepatitis C virus eradication in people living with human immunodeficiency virus: Where are we now?
- Browse: 115 Download: 122 Issue Date: 2024-05-27